FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313299667> ?p ?o ?g. }

• W4313299667 endingPage "159101992211488" @default.
• W4313299667 startingPage "159101992211488" @default.
• W4313299667 abstract "Objective To describe the off-label uses of pipeline embolization device for a variety of types of aneurysms including ruptured aneurysms, posterior circulation aneurysms, small aneurysms, distal aneurysms, and recurrent aneurysms. Methods Clinical and angiographic data of patients who underwent pipeline embolization device treatment on off-label use at our center were retrospectively reviewed. For categorical variables, Fisher's exact test was used, and a two-sample Wilcoxon rank-sum test was used for patients’ age to analyze the correlation with outcomes. Results In this study, 121 aneurysms in 107 patients received off-label pipeline embolization device treatments. The overall rate of complete aneurysm occlusion was 77.8% (28/36 in 35 patients) for posterior circulation aneurysms and 95.3% (81/85 in 72 patients) for anterior circulation aneurysms. The posterior circulation aneurysms have a lower rate of aneurysm occlusion ( p = 0.0372). The small aneurysms have a higher rate of aneurysm occlusion ( p = 0.0104). The patient's sex, age, and aneurismal size were associated with ischemic stroke complications ( p = 0.0397, 0.0166, and 0.0178). In posterior circulation aneurysm patients, only two basilar apex aneurysms underwent pipeline embolization device treatment, both of whom died of thrombotic complications. There was no difference in mortality between posterior circulation aneurysm patients (8.6%, 3/35) and anterior circulation aneurysm patients (1.4%, 1/72) ( p = 0.1015). Patients of older age have a higher risk of death rate ( p = 0.0053). Conclusions The off-label use of pipeline embolization device is often performed in clinical practice and can achieve efficacy in complex aneurysms. The off-label use of pipeline embolization device was found to carry an increased rate of mortality in older patients. Excluding basilar apex aneurysms, the pipeline embolization device is as safe as anterior circulation aneurysms in the treatment of posterior circulation aneurysms elsewhere." @default.
• W4313299667 created "2023-01-06" @default.
• W4313299667 creator A5019435210 @default.
• W4313299667 creator A5028383129 @default.
• W4313299667 creator A5029473599 @default.
• W4313299667 creator A5084379028 @default.
• W4313299667 date "2022-12-30" @default.
• W4313299667 modified "2023-10-16" @default.
• W4313299667 title "The off-label uses of pipeline embolization device for complex cerebral aneurysms: Mid-term follow-up in a single center" @default.
• W4313299667 cites W1894449666 @default.
• W4313299667 cites W2191459404 @default.
• W4313299667 cites W2336966588 @default.
• W4313299667 cites W2416337330 @default.
• W4313299667 cites W2461481069 @default.
• W4313299667 cites W2570413398 @default.
• W4313299667 cites W2614640029 @default.
• W4313299667 cites W2620696175 @default.
• W4313299667 cites W2620766331 @default.
• W4313299667 cites W2762599012 @default.
• W4313299667 cites W2990698436 @default.
• W4313299667 cites W2995516085 @default.
• W4313299667 cites W2996023173 @default.
• W4313299667 cites W3009875803 @default.
• W4313299667 cites W3043761830 @default.
• W4313299667 cites W3164165751 @default.
• W4313299667 cites W3166237249 @default.
• W4313299667 cites W3172985046 @default.
• W4313299667 cites W4207078892 @default.
• W4313299667 doi "https://doi.org/10.1177/15910199221148800" @default.
• W4313299667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36583531" @default.
• W4313299667 hasPublicationYear "2022" @default.
• W4313299667 type Work @default.
• W4313299667 citedByCount "1" @default.
• W4313299667 countsByYear W43132996672023 @default.
• W4313299667 crossrefType "journal-article" @default.
• W4313299667 hasAuthorship W4313299667A5019435210 @default.
• W4313299667 hasAuthorship W4313299667A5028383129 @default.
• W4313299667 hasAuthorship W4313299667A5029473599 @default.
• W4313299667 hasAuthorship W4313299667A5084379028 @default.
• W4313299667 hasConcept C126838900 @default.
• W4313299667 hasConcept C141071460 @default.
• W4313299667 hasConcept C191093355 @default.
• W4313299667 hasConcept C2776035437 @default.
• W4313299667 hasConcept C2776098176 @default.
• W4313299667 hasConcept C2776268601 @default.
• W4313299667 hasConcept C71924100 @default.
• W4313299667 hasConceptScore W4313299667C126838900 @default.
• W4313299667 hasConceptScore W4313299667C141071460 @default.
• W4313299667 hasConceptScore W4313299667C191093355 @default.
• W4313299667 hasConceptScore W4313299667C2776035437 @default.
• W4313299667 hasConceptScore W4313299667C2776098176 @default.
• W4313299667 hasConceptScore W4313299667C2776268601 @default.
• W4313299667 hasConceptScore W4313299667C71924100 @default.
• W4313299667 hasLocation W43132996671 @default.
• W4313299667 hasLocation W43132996672 @default.
• W4313299667 hasOpenAccess W4313299667 @default.
• W4313299667 hasPrimaryLocation W43132996671 @default.
• W4313299667 hasRelatedWork W1860205706 @default.
• W4313299667 hasRelatedWork W2077760523 @default.
• W4313299667 hasRelatedWork W2166522426 @default.
• W4313299667 hasRelatedWork W2375269857 @default.
• W4313299667 hasRelatedWork W2380139392 @default.
• W4313299667 hasRelatedWork W2753981613 @default.
• W4313299667 hasRelatedWork W2910973399 @default.
• W4313299667 hasRelatedWork W3185679269 @default.
• W4313299667 hasRelatedWork W4243702326 @default.
• W4313299667 hasRelatedWork W4289526164 @default.
• W4313299667 isParatext "false" @default.
• W4313299667 isRetracted "false" @default.
• W4313299667 workType "article" @default.